Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty
NCT ID: NCT03047499
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2 participants
OBSERVATIONAL
2017-02-15
2017-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.
NCT07137234
Botulinum Toxin Injection in Reducing Lip Scar Following Cleft Lip Repair
NCT05559281
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
NCT02247193
Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars
NCT04756882
Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection
NCT03186547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scar Length
Botulinum toxin type A
Botulinum toxin type-A injection
Vancouver scar scale
Botulinum toxin type A
Botulinum toxin type-A injection
Scar width
Botulinum toxin type A
Botulinum toxin type-A injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Botulinum toxin type A
Botulinum toxin type-A injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Months
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mostafa Khairy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa Khairy
Mostafa Khairy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rehab Tariq Elsharkawy, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBC-CU-2017-02-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.